Comparison of different preparation and storage methods for allogeneic platelet lysate
10.13303/j.cjbt.issn.1004-549x.2026.10.005
- VernacularTitle:同种异体血小板裂解液不同制备及储存方式的对比研究
- Author:
Xin CHEN
1
;
Haining WANG
2
;
Xiaobao SHAO
1
;
Xue RUI
1
;
Fengwei GAO
1
;
Yuan YANG
1
;
Hua WANG
1
;
Yi LIU
1
;
Lin ZHOU
1
;
Yudong DAI
2
;
Peiyuan ZHU
1
Author Information
1. Department of Blood Transfusion, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing 210022China
2. Nanjing Red Cross Blood Center, Nanjing 210003, China
- Publication Type:Journal Article
- Keywords:
platelet lysate;
allogeneic;
preparation method;
storage duration;
growth factor
- From:
Chinese Journal of Blood Transfusion
2026;39(10):1347-1354
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the effects of different preparation methods and storage conditions on growth factor concentrations in allogeneic platelet lysate (PL). Methods: Whole blood was collected from blood donors (n=13), and platelet-rich plasma (PRP) was isolated using the buffy coat method. PL was prepared via three protocols: Group A (thrombinactivated, stored at -80℃), Group B (three freezethaw cycles at -30℃/37℃, stored at -30℃), and Group C (three freezethaw cycles at -80℃/37℃, stored at -80℃). The concentrations of growth factors (IGF-1, VEGF, PDGF-AB and EGF) in all the groups were measured by ELISA at 1, 3, 6, 9, and 12 months. Results: From month1 to month 6, the concentrations of all four growth factors remained stable, and there was no significant decrease in any of the three groups (P>0.05). At month 9, certain factors exhibited signs of degradation. Specifically, VEGF levels in the three groups (240.79±41.93, 189.32±4.32, and 188.85±3.99) were significantly decreased compared with those at month 1 (279.04±48.01, 306.89±34.40, and 305.10±27.53) (P<0.01); PDGFAB levels in the three groups (292.93±195.44, 329.03±254.93, and 559.83±518.46) were markedly lower than those at month 1 (796.89±185.88, 903.85±262.34, and 888.95±362.40) (P<0.05); and EGF in Group A at month 9 (57.15±74.43) was significantly reduced relative to the levels measured from 1 to 6 months (207.46±26.00, 202.20±51.46, and 224.62±55.99) (P<0.01). At month 12, IGF1 concentrations in the three groups (38.68±27.59, 24.22±18.31, and 16.54±6.02) were significantly lower than those at month 9 (79.38±22.42, 60.13±27.69, and 42.46±17.42); VEGF levels in the three groups (161.55±15.05, 150.72±15.58, and 158.09±26.39) were significantly lower than those at month 1 (279.04±48.01, 306.89±34.40, and 305.10±27.53); PDGFAB levels in the three groups (340.89±187.90, 364.13±204.44, and 496.36±291.43) were significantly lower than those at month 1 (796.89±185.88、903.85±263.34 and 888.95±362.40); and EGF levels in the three groups (141.48±7.34, 137.94±1.05, and 139.25±1.72) were significantly lower than those at month 1 (207.46±26.00, 202.99±38.53, and 209.89±33.87) (all P<0.01). Intergroup comparisons revealed that IGF1 levels in Group A (47.68±17.89, 79.38±22.42, and 38.68±27.59) were higher than those in Group C (25.80±13.93, 42.46±17.42, and 16.54±6.02) from 6 to 12 months (P<0.05). At month 9, VEGF in Group A (240.79±41.93) was significantly higher than in the freezethaw groups (189.32±4.32 and 188.85±3.99) (P<0.01), whereas EGF in Group A at month 9 (57.15±74.43) was significantly lower than in the freezethaw groups (201.56±111.82 and 159.36±99.24) (P<0.05). The overall degradation trends of PL prepared by repeated freezethawing (both -30℃ and -80℃) and by thrombin activation (-80℃) were generally consistent, and no significant difference was observed between storage at -30℃ and -80℃ for freezethawed PL. Conclusion: The repeated freezethaw method, being operationally simple, safer, and more cost-effective, can be recommended as the preferred preparation approach for PL. The combined protocol of repeated freezethaw at -30℃ followed by storage at -30℃ yields effects equivalent to the -80℃ scheme for up to 6 months.